Funded Startups in Ecublens
In Ecublens, the largest disclosed funding in the 13 most recent rows is Lymphatica Medtech’s $20M Series B on 2024-10-08, and it sits above a low-disclosu…
In Ecublens, the largest disclosed funding in the 13 most recent rows is Lymphatica Medtech’s $20M Series B on 2024-10-08, and it sits above a low-disclosure field that includes several rounds under $10M (e.g., CREAL $9M on 2025-07-10; Zaphiro Technologies $7M on 2022-12-19; Nanolive $2M on 2022-09-20). The clearest outlier on the downside is Composite Recycling’s $30K disclosed amount on 2023-05-02, while three entries are not comparable on amount because they are marked undisclosed (Picterra on 2024-10-07; AMF Medical SA on 2021-11-01; Enerdrape $520K is disclosed but several others are not).
The list also shows cluster behavior by date and sector: 5 of 13 rows fall between 2024-10-07 and 2025-02-21 (Picterra 2024-10-07 undisclosed; Lymphatica Medtech 2024-10-08 $20M; bNovate Technologies 2025-02-21 $4M; CREAL 2025-07-10 $9M; Enerdrape 2026-02-24 $520K). Sector concentration is also noticeable, with Energy appearing 3 times (Enerdrape 2026-02-24 $520K; CREAL 2025-07-10 $9M; Zaphiro Technologies 2022-12-19 $7M; SoHHytec 2022-01-20 $2M), and Biotechnology appearing 4 times (bNovate Technologies 2025-02-21 $4M; Lymphatica Medtech 2024-10-08 $20M; Anokion 2022-10-18 $35M; Nanolive 2022-09-20 $2M). Rounds span from 2021-10-04 (Alpine Intuition convertible note $100K) to 2026-02-24 (Enerdrape).
Most recent rounds
13 shownRelated listings
Frequently asked
What’s the biggest disclosed round in Ecublens in these 13 rows, and how far above the rest is it?
Lymphatica Medtech’s $20M Series B on 2024-10-08 is the highest disclosed amount in the table; the next-highest disclosed amounts are Anokion at $35M (2022-10-18), so the top of the disclosed range is driven by Anokion, while $20M remains one of only a few large disclosed rounds alongside CREAL ($9M on 2025-07-10) and Zaphiro Technologies ($7M on 2022-12-19).
Do any companies/rounds cluster into a narrow time window rather than being evenly spread?
Yes: 4 entries fall from 2024-10-07 through 2025-02-21 (Picterra 2024-10-07 undisclosed; Lymphatica Medtech 2024-10-08 $20M; bNovate Technologies 2025-02-21 $4M), with an additional Energy round shortly after in this later window (CREAL on 2025-07-10 $9M).
Which entries look like amount outliers relative to the disclosed range?
Composite Recycling’s $30K disclosed amount (2023-05-02) is the smallest disclosed figure in the list; at the other extreme, the top end of disclosed amounts includes Anokion at $35M (2022-10-18) and Lymphatica Medtech at $20M (2024-10-08), creating a wide disclosed spread around these two highs.
Is there stage concentration, or do multiple stages appear with similar frequency?
Stage labels are fragmented, but some patterns stand out: there is only one explicit Seed round (SoHHytec $2M on 2022-01-20), one Series B (Lymphatica Medtech $20M on 2024-10-08), and two explicit Series C/Series A appear in different periods (Nanolive Series C $2M on 2022-09-20; Zaphiro Technologies Series A $7M on 2022-12-19 and Embion Technologies Series A $5M on 2021-12-08).
How common are missing/disclosed amounts compared with reported amounts?
Amounts are missing in at least 2 rows labeled undisclosed (Picterra on 2024-10-07 and AMF Medical SA on 2021-11-01). The remaining rows provide disclosed amounts, including several low-to-mid single digit millions such as bNovate Technologies $4M (2025-02-21), Nanolive $2M (2022-09-20), and Embion Technologies $5M (2021-12-08).
Are any sectors over-represented among these 13 companies?
Energy and Biotechnology recur: Energy appears 4 times (Enerdrape 2026-02-24 $520K; CREAL 2025-07-10 $9M; Zaphiro Technologies 2022-12-19 $7M; SoHHytec 2022-01-20 $2M), while Biotechnology also appears 4 times (bNovate Technologies 2025-02-21 $4M; Lymphatica Medtech 2024-10-08 $20M; Anokion 2022-10-18 $35M; Nanolive 2022-09-20 $2M).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.